|
End-of-day quote
Shenzhen S.E.
2026-10-28
|
5-day change | 1st Jan Change | ||
| 11.56 CNY | -0.69% |
|
-2.20% | -19.50% |
| Market Cap | 3.37B 506M 454M 420M 380M 710M 48.17B 718M 5.02B 2B 25.21B 1.9B 1.86B 80.02B | P/E 2024 |
23.5x | P/E 2025 | 37.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.74B 411M 368M 341M 309M 576M 39.12B 583M 4.07B 1.62B 20.47B 1.54B 1.51B 64.98B | EV / Sales 2024 |
0.18x | EV / Sales 2025 | 0.18x |
| Free-Float |
57.75% | Yield 2024 |
1.32% | Yield 2025 | 0.8% |
| 1 day | -0.69% | ||
| 1 week | -2.20% | ||
| Current month | -5.71% | ||
| 1 month | -5.56% | ||
| 3 months | +1.31% | ||
| 6 months | -16.71% | ||
| Current year | -19.50% |
| 1 week | 11.26 |  | 11.9 |
| 1 month | 11.26 | | 12.53 |
| Current year | 10.57 | | 19.69 |
| 1 year | 10.57 | | 19.69 |
| 3 years | 9.78 | | 19.69 |
| 5 years | 9.78 | | 20.7 |
| 10 years | 9.78 | | 43.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Bin Huang
PSD | President | 55 | 2021-08-11 |
Wei Gao
PRN | Corporate Officer/Principal | 54 | 2019-11-30 |
Xue Tian Dong
AUD | Comptroller/Controller/Auditor | 37 | 2014-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Lin
BRD | Director/Board Member | 57 | 2022-12-13 |
Wei Pan
BRD | Director/Board Member | 55 | 2022-12-13 |
Li Jun Zhang
CHM | Chairman | 62 | 2018-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.69% | -2.20% | -17.31% | -17.01% | 509M | |
| +0.50% | +1.38% | +57.09% | +127.73% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +84.34% | 647B | |
| -0.14% | +0.42% | +25.69% | +101.56% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.25% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.19% | +2.89% | +24.92% | 265B | |
| +0.87% | +3.08% | +54.69% | +71.67% | 242B | |
| +0.08% | +3.67% | +35.05% | +104.71% | 197B | |
| Average | +0.19% | +0.81% | +33.94% | +65.72% | 402.8B | |
| Weighted average by Cap. | +0.51% | +0.71% | +43.75% | +87.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 24.02B 3.6B 3.23B 2.99B 2.71B 5.06B 343B 5.12B 35.73B 14.23B 180B 13.52B 13.23B 570B | 19.53B 2.93B 2.63B 2.43B 2.2B 4.11B 279B 4.16B 29.04B 11.57B 146B 10.99B 10.76B 463B |
| Net income | 161M 24.1M 21.62M 19.99M 18.1M 33.82M 2.3B 34.23M 239M 95.2M 1.2B 90.43M 88.52M 3.81B | 111M 16.71M 14.99M 13.86M 12.55M 23.45M 1.59B 23.73M 166M 65.99M 833M 62.69M 61.37M 2.64B |
| Net Debt | 642M 96.35M 86.44M 79.92M 72.38M 135M 9.18B 137M 956M 381M 4.8B 362M 354M 15.24B | -634M -95.07M -85.29M -78.86M -71.42M -133M -9.05B -135M -943M -376M -4.74B -357M -349M -15.04B |
Employees
1,741
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | CN¥11.56 | -0.69% | 2,415,013 |
| 26-10-27 | CN¥11.64 | -1.69% | 2,138,000 |
| 26-10-26 | CN¥11.84 | +1.98% | 2,659,743 |
| 26-10-23 | CN¥11.61 | +0.96% | 3,887,550 |
| 26-10-22 | CN¥11.50 | -2.46% | 2,769,600 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002462 Stock
Select your edition
All financial news and data tailored to specific country editions
